Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Simon

Showing results (131-140 of 203) with videos related to

Pageof 21
Sort By:
Melanoma Research|March 15, 2024
Retrospective comparison of a weight-based dose every 2 weeks with a fixed dose every month: a real-life analysis of nivolumab in the treatment of advanced melanomaMarie Leroy, Eve Desmedt, Laure Deramoudt, et al.
Current Pharmaceutical Design|June 20, 2015
Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription TrendsLouise Carton, Olivier Cottencin, Maryse Lapeyre-Mestre, et al.
Therapeutic Drug Monitoring|September 23, 2008
Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patientsCaroline Solas, Marie-Claude Gagnieu, Isabelle Ravaux, et al.
Therapeutic Drug Monitoring|July 12, 2014
Unexpected overestimation of methotrexate plasma concentrations: analysis of a single center pediatric populationEmilie Guerriero, Nicolas Simon, Brigitte Nelken, et al.
BMC Medicine|June 19, 2026
Daily alcohol consumption trajectories and user retention during a national temporary abstinence campaign: real-world data from a smartphone applicationMickael Naassila, Nicolas Simon, Judith André, et al.
Clinical Pharmacokinetics|April 28, 2006
Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patientsNicolas Simon, Bertrand Dussol, Emmanuelle Sampol, et al.
The Annals of Pharmacotherapy|January 12, 2022
Impact of Defibrotide in the Prevention of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell TransplantationRémi Tilmont, Ibrahim Yakoub-Agha, Nassima Ramdane, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2003
Pharmacokinetics of the low molecular weight heparin enoxaparin during 48 h after bolus administration as an anticoagulant in haemodialysisBenjamin Guillet, Nicolas Simon, Jérôme José Sampol, et al.
Cancer Chemotherapy and Pharmacology|January 13, 2021
Does bevacizumab increase joint pain in patients with cancer? Results of the prospective observational BEVARTHRALGIA studyEnora Vauléon, Hélène Behal, Loïc Lebellec, et al.
Bulletin Du Cancer|November 28, 2017
[Dose adaptation of the drugs used for hematopoietic stem-cell transplantation in patients with comorbidity: Obesity, chronic renal disease or hepatopathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Nicolas Simon, Valérie Coiteux, Bénédicte Bruno, et al.
Pageof 21

Showing results (131-140 of 203) with videos related to

Sort By:
Pageof 21
Melanoma Research|March 15, 2024
Retrospective comparison of a weight-based dose every 2 weeks with a fixed dose every month: a real-life analysis of nivolumab in the treatment of advanced melanomaMarie Leroy, Eve Desmedt, Laure Deramoudt, et al.
Current Pharmaceutical Design|June 20, 2015
Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription TrendsLouise Carton, Olivier Cottencin, Maryse Lapeyre-Mestre, et al.
Therapeutic Drug Monitoring|September 23, 2008
Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patientsCaroline Solas, Marie-Claude Gagnieu, Isabelle Ravaux, et al.
Therapeutic Drug Monitoring|July 12, 2014
Unexpected overestimation of methotrexate plasma concentrations: analysis of a single center pediatric populationEmilie Guerriero, Nicolas Simon, Brigitte Nelken, et al.
BMC Medicine|June 19, 2026
Daily alcohol consumption trajectories and user retention during a national temporary abstinence campaign: real-world data from a smartphone applicationMickael Naassila, Nicolas Simon, Judith André, et al.
Clinical Pharmacokinetics|April 28, 2006
Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patientsNicolas Simon, Bertrand Dussol, Emmanuelle Sampol, et al.
The Annals of Pharmacotherapy|January 12, 2022
Impact of Defibrotide in the Prevention of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell TransplantationRémi Tilmont, Ibrahim Yakoub-Agha, Nassima Ramdane, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2003
Pharmacokinetics of the low molecular weight heparin enoxaparin during 48 h after bolus administration as an anticoagulant in haemodialysisBenjamin Guillet, Nicolas Simon, Jérôme José Sampol, et al.
Cancer Chemotherapy and Pharmacology|January 13, 2021
Does bevacizumab increase joint pain in patients with cancer? Results of the prospective observational BEVARTHRALGIA studyEnora Vauléon, Hélène Behal, Loïc Lebellec, et al.
Bulletin Du Cancer|November 28, 2017
[Dose adaptation of the drugs used for hematopoietic stem-cell transplantation in patients with comorbidity: Obesity, chronic renal disease or hepatopathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Nicolas Simon, Valérie Coiteux, Bénédicte Bruno, et al.
Pageof 21